Vaccine updates
J&J pauses vaccine production, but SA stands strong with own clone in the pipeline
Many countries in the developing world will see a shortfall, says New York Times
15 February 2022 - 11:25
Johnson & Johnson (J&J) has temporarily paused production of their Covid-19 vaccine to pursue something more lucrative, but SA will not fall victim to the shortfall.
The pause in production, according to the New York Times (https://www.nytimes.com/2022/02/08/business/johnson-johnson-covid-vaccine.html), is a worry for much of the developing world as the J&J vaccine is their main supply in the fight against Covid-19...
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Already subscribed? Simply sign in below.
Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.
Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.